Rochester, NY, United States of America

John R Minter


Average Co-Inventor Count = 3.4

ph-index = 2

Forward Citations = 239(Granted Patents)


Company Filing History:


Years Active: 1997-1998

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by John R Minter in Nanoparticulate Pharmaceutical Agents

Introduction

John R Minter is a notable inventor based in Rochester, NY (US). He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of nanoparticulate agents. With a total of 2 patents, Minter's work focuses on enhancing the bioavailability of pharmaceutical agents through innovative processes.

Latest Patents

Minter's latest patents include "Microprecipitation of nanoparticulate pharmaceutical agents using" and "Microprecipitation of micro-nanoparticulate pharmaceutical agents." The first patent describes a process for preparing nanoparticulate pharmaceutical agent dispersions. This involves dissolving the pharmaceutical agent in an alkaline solution and neutralizing it with an acid, using surface-modifying agents to create fine particle dispersions. The resulting microcrystalline particles have Z-average diameters smaller than 400 nm, which are crucial for large-scale manufacturing.

The second patent highlights the importance of administering pharmaceutical agents with poor water solubility in the form of particles less than 400 nm in diameter. Minter discovered that chemical derivatization of certain photographic coupler molecules can lead to the preparation of nanoparticulate dispersions. This process also results in ultra-fine particles with diameters as small as 10 nm, suitable for large-scale production.

Career Highlights

Minter is currently associated with Nanosystems L.L.C., where he continues to innovate in the field of pharmaceutical technology. His work has been instrumental in advancing the methods of drug formulation, making significant strides in improving the efficacy of therapeutic agents.

Collaborations

Minter has collaborated with notable colleagues such as Pranab Bagchi and Gregory L McIntire. Their combined expertise has contributed to the successful development of Minter's innovative processes and patents.

Conclusion

John R Minter's contributions to the field of nanoparticulate pharmaceutical agents demonstrate his commitment to enhancing drug delivery systems. His innovative patents and ongoing work at Nanosystems L.L.C. continue to pave the way for advancements in pharmaceutical sciences.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…